Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · IEX Real-Time Price · USD
1.920
+0.020 (1.05%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Rockwell Medical Revenue
Rockwell Medical had revenue of $86.62M in the twelve months ending March 31, 2024, with 13.45% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $22.68M with 15.29% year-over-year growth. In the year 2023, Rockwell Medical had annual revenue of $83.61M with 14.84% growth.
Revenue (ttm)
$86.62M
Revenue Growth
+13.45%
P/S Ratio
0.67
Revenue / Employee
$365,485
Employees
237
Market Cap
58.21M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 83.61M | 10.80M | 14.84% |
Dec 31, 2022 | 72.81M | 10.88M | 17.57% |
Dec 31, 2021 | 61.93M | -266.00K | -0.43% |
Dec 31, 2020 | 62.20M | 894.00K | 1.46% |
Dec 31, 2019 | 61.30M | -2.09M | -3.29% |
Dec 31, 2018 | 63.39M | 6.09M | 10.63% |
Dec 31, 2017 | 57.30M | 4.02M | 7.54% |
Dec 31, 2016 | 53.28M | -2.07M | -3.73% |
Dec 31, 2015 | 55.35M | 1.16M | 2.14% |
Dec 31, 2014 | 54.19M | 1.81M | 3.45% |
Dec 31, 2013 | 52.38M | 2.54M | 5.09% |
Dec 31, 2012 | 49.84M | 876.16K | 1.79% |
Dec 31, 2011 | 48.97M | -10.59M | -17.78% |
Dec 31, 2010 | 59.55M | 4.83M | 8.82% |
Dec 31, 2009 | 54.73M | 3.06M | 5.93% |
Dec 31, 2008 | 51.67M | 8.62M | 20.03% |
Dec 31, 2007 | 43.05M | 14.41M | 50.30% |
Dec 31, 2006 | 28.64M | 943.90K | 3.41% |
Dec 31, 2005 | 27.69M | 9.75M | 54.33% |
Dec 31, 2004 | 17.94M | 2.97M | 19.87% |
Dec 31, 2003 | 14.97M | 3.47M | 30.22% |
Dec 31, 2002 | 11.50M | 2.48M | 27.51% |
Dec 31, 2001 | 9.02M | 1.56M | 20.90% |
Dec 31, 2000 | 7.46M | 768.09K | 11.48% |
Dec 31, 1999 | 6.69M | 1.42M | 26.86% |
Dec 31, 1998 | 5.27M | 1.95M | 58.87% |
Dec 31, 1997 | 3.32M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Neuronetics | 73.23M |
Cryo-Cell International | 31.64M |
ProPhase Labs | 28.72M |
InspireMD | 6.48M |
Adlai Nortye | 5.00M |
Enzo Biochem | 4.72M |
VolitionRx | 797.03K |
RMTI News
- 7 days ago - Rockwell Medical to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference - Business Wire
- 11 days ago - Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024 - Business Wire
- 7 weeks ago - Rockwell Medical Promotes Tim Chole to Chief Commercial Officer - Business Wire
- 2 months ago - Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance - Business Wire
- 3 months ago - Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States - Business Wire
- 3 months ago - Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024 - Business Wire
- 3 months ago - Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda - Business Wire
- 4 months ago - Rockwell Medical Named 'Great Place to Work' for Second Year in a Row - Business Wire